Table 4. Acute Asthma Outcome Frequencies in the Matched Sample of Patients Receiving the Electronic Asthma Action Plan Decision Support Tool
Outcomes by Follow-up TimeChildrenAdults
eAAP (n = 2783)Control (n = 2783)eAAP (n = 892)Control (n = 892)
ED visit, n (%)
    3 months after31 (1.1)26 (0.9)14 (1.6)10 (1.1)
    6 months after56 (2.0)53 (1.9)20 (2.2)18 (2.0)
    12 months after89 (3.2)84 (3.0)29 (3.3)23 (2.6)
Hospitalization, n (%)
    3 months after6 (0.2)11 (0.4)2 (0.2)1 (0.1)
    6 months after12 (0.4)15 (0.5)3 (0.3)4 (0.4)
    12 months after16 (0.6)18 (0.6)6 (0.7)4 (0.4)
Outpatient oral steroid, n (%)
    3 months after162 (5.8)223 (8.0)62 (7.0)76 (8.5)
    6 months after237 (8.5)297 (10.7)88 (9.9)93 (10.4)
    12 months after219 (7.9)311 (11.2)60 (6.7)60 (6.7)
Any exacerbation, n (%)
    3 months after194 (7.0)250 (9.0)76 (8.5)84 (9.4)
    6 months after282 (10.1)329 (11.8)105 (11.8)107 (12.0)
    12 months after261 (9.4)344 (12.4)76 (8.5)70 (7.8)*
  • * Counts for outcomes 3, 6, and 12 months after the intervention include only patients with enough follow-up to capture those outcomes.

  • eAAP, electronic asthma action plan decision support tool; ED, emergency department.